Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Third Quarter Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Third Quarter Financial Results

Lexicon Pharma (LXRX) Tops Q3 EPS by 14c

November 1, 2016 8:15 AM EDT

Lexicon Pharma (NASDAQ: LXRX) reported Q3 EPS of ($0.35), $0.14 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $27.7 million versus the consensus estimate of $9.68 million.

For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.

... More